106 related articles for article (PubMed ID: 15196618)
1. A new way to estimate the contribution of a risk factor in populations avoided nonadditivity.
Llorca J; Delgado-Rodríguez M
J Clin Epidemiol; 2004 May; 57(5):479-83. PubMed ID: 15196618
[TBL] [Abstract][Full Text] [Related]
2. Generalized approaches to partitioning the attributable risk of interacting risk factors can remedy existing pitfalls.
Rabe C; Lehnert-Batar A; Gefeller O
J Clin Epidemiol; 2007 May; 60(5):461-8. PubMed ID: 17419957
[TBL] [Abstract][Full Text] [Related]
3. [A method for measuring the contribution of individual factor to disease caused by multiple risk factors].
He HQ; Chen K; Zhou M; Tong F
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):374-7. PubMed ID: 16053769
[TBL] [Abstract][Full Text] [Related]
4. Local estimates of population attributable risk.
Walter SD
J Clin Epidemiol; 2010 Jan; 63(1):85-93. PubMed ID: 19403265
[TBL] [Abstract][Full Text] [Related]
5. Why population attributable fractions can sum to more than one.
Rowe AK; Powell KE; Flanders WD
Am J Prev Med; 2004 Apr; 26(3):243-9. PubMed ID: 15026106
[TBL] [Abstract][Full Text] [Related]
6. Applications of the concept of attributable fraction in medical genetics.
Khoury MJ; Beaty TH; Cohen BH
Am J Med Genet; 1991 Aug; 40(2):177-82. PubMed ID: 1832818
[TBL] [Abstract][Full Text] [Related]
7. Average attributable fractions: a coherent theory for apportioning excess risk to individual risk factors and subpopulations.
Eide GE; Heuch I
Biom J; 2006 Aug; 48(5):820-37. PubMed ID: 17094346
[TBL] [Abstract][Full Text] [Related]
8. Update of potency factors for asbestos-related lung cancer and mesothelioma.
Berman DW; Crump KS
Crit Rev Toxicol; 2008; 38 Suppl 1():1-47. PubMed ID: 18671157
[TBL] [Abstract][Full Text] [Related]
9. Estimating the proportion of disease due to classes of sufficient causes.
Hoffmann K; Heidemann C; Weikert C; Schulze MB; Boeing H
Am J Epidemiol; 2006 Jan; 163(1):76-83. PubMed ID: 16293718
[TBL] [Abstract][Full Text] [Related]
10. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
11. An attributable risk model for exposures assumed to cause both chronic disease and its exacerbations.
Künzli N; Perez L; Lurmann F; Hricko A; Penfold B; McConnell R
Epidemiology; 2008 Mar; 19(2):179-85. PubMed ID: 18300713
[TBL] [Abstract][Full Text] [Related]
12. Did it fall or was it pushed? The contribution of trends in established risk factors to the decline in premature coronary heart disease mortality in New Zealand.
Tobias M; Taylor R; Yeh LC; Huang K; Mann S; Sharpe N
Aust N Z J Public Health; 2008 Apr; 32(2):117-25. PubMed ID: 18412680
[TBL] [Abstract][Full Text] [Related]
13. Attributable fractions for partitioning risk and evaluating disease prevention: a practical guide.
Eide GE
Clin Respir J; 2008 Oct; 2 Suppl 1():92-103. PubMed ID: 20298357
[TBL] [Abstract][Full Text] [Related]
14. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
15. How to anticipate the assessment of the public health benefit of new medicines?
Massol J; Puech A; Boissel JP;
Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
[TBL] [Abstract][Full Text] [Related]
16. Polytomous disease mapping to detect uncommon risk factors for related diseases.
Dreassi E
Biom J; 2007 Aug; 49(4):520-9. PubMed ID: 17634979
[TBL] [Abstract][Full Text] [Related]
17. Glaucoma risk factor assessment and prevention: lessons from coronary heart disease.
Girkin CA; Kannel WB; Friedman DS; Weinreb RN
Am J Ophthalmol; 2004 Sep; 138(3 Suppl):S11-8. PubMed ID: 15364048
[TBL] [Abstract][Full Text] [Related]
18. Beyond subgroup analysis: improving the clinical interpretation of treatment effects in stroke research.
Lu M; Lyden PD; Brott TG; Hamilton S; Broderick JP; Grotta JC
J Neurosci Methods; 2005 Apr; 143(2):209-16. PubMed ID: 15814153
[TBL] [Abstract][Full Text] [Related]
19. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
20. Radon exposure assessment and dosimetry applied to epidemiology and risk estimation.
Puskin JS; James AC
Radiat Res; 2006 Jul; 166(1 Pt 2):193-208. PubMed ID: 16808608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
